$263 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 60 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 26.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| REGN | Buy | REGENERON PHARMACEUTICALS | $23,639,000 | +35.2% | 48,130 | +6.6% | 8.98% | +34.2% |
| CELG | Buy | CELGENE CORP | $23,053,000 | +6.5% | 177,522 | +2.0% | 8.76% | +5.7% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $17,465,000 | +30.4% | 135,522 | +10.6% | 6.64% | +29.4% |
| BIIB | Sell | BIOGEN INC | $16,577,000 | -19.6% | 61,108 | -19.0% | 6.30% | -20.2% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $11,758,000 | -22.2% | 96,641 | -22.5% | 4.47% | -22.8% |
| BMRN | Buy | BIOMARIN PHARMACEUTICALS INC | $10,732,000 | +57.4% | 118,166 | +52.1% | 4.08% | +56.2% |
| INCY | Sell | INCYTE CORP | $9,755,000 | -42.8% | 77,475 | -39.2% | 3.71% | -43.2% |
| AMGN | Sell | AMGEN INC | $8,629,000 | -21.6% | 50,104 | -25.3% | 3.28% | -22.2% |
| GILD | Buy | GILEAD SCIENCES INC | $8,619,000 | +24.7% | 121,784 | +19.6% | 3.28% | +23.8% |
| ENTL | ENTELLUS MED INC | $5,655,000 | +20.3% | 341,468 | 0.0% | 2.15% | +19.4% | |
| MYL | New | MYLAN NV | $5,433,000 | – | 140,000 | +100.0% | 2.06% | – |
| SHPG | Sell | SHIRE PLCsponsored adr | $5,404,000 | -54.5% | 32,700 | -52.1% | 2.05% | -54.9% |
| XLRN | Buy | ACCELERON PHARMA INC | $5,397,000 | +19.6% | 177,643 | +4.1% | 2.05% | +18.7% |
| RDUS | Buy | RADIUS HEALTH INC | $5,194,000 | +579.0% | 114,799 | +479.8% | 1.97% | +573.7% |
| EXEL | Buy | EXELIXIS INC | $5,096,000 | +79.6% | 207,000 | +58.0% | 1.94% | +78.3% |
| Buy | NEURODERM LTD | $5,007,000 | +74.5% | 168,025 | +55.2% | 1.90% | +73.3% | |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $4,926,000 | +624.4% | 93,822 | +525.5% | 1.87% | +620.0% |
| TSRO | Buy | TESARO INC | $4,685,000 | +29.6% | 33,500 | +42.6% | 1.78% | +28.6% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $4,269,000 | +318.9% | 76,000 | +192.3% | 1.62% | +315.9% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $4,199,000 | +7.2% | 27,000 | 0.0% | 1.60% | +6.4% | |
| STML | Buy | STEMLINE THERAPEUTICS INC | $4,168,000 | +48.6% | 453,000 | +37.3% | 1.58% | +47.5% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $3,842,000 | +125.1% | 137,773 | +177.5% | 1.46% | +123.6% |
| DERM | Buy | DERMIRA INC | $3,756,000 | +4.9% | 129,000 | +22.9% | 1.43% | +4.2% |
| CALA | Buy | CALITHERA BIOSCIENCES INC | $3,623,000 | +236.1% | 244,000 | +161.5% | 1.38% | +233.4% |
| SGYPQ | Buy | SYNERGY PHARMACEUTICALS DEL | $3,428,000 | +136.3% | 772,000 | +147.4% | 1.30% | +134.8% |
| SGEN | SEATTLE GENETICS INC | $3,363,000 | -17.7% | 65,000 | 0.0% | 1.28% | -18.3% | |
| AKAOQ | Sell | ACHAOGEN INC | $3,358,000 | -52.5% | 154,538 | -44.8% | 1.28% | -52.8% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $3,276,000 | +157.3% | 35,000 | +75.0% | 1.24% | +155.6% |
| ADMS | ADAMAS PHARMACEUTICALS INC | $3,236,000 | 0.0% | 185,234 | 0.0% | 1.23% | -0.7% | |
| New | UNITED THERAPEUTICS CORP DEL | $2,815,000 | – | 21,700 | +100.0% | 1.07% | – | |
| ARRY | Buy | ARRAY BIOPHARMA INC | $2,681,000 | +286.9% | 320,744 | +313.9% | 1.02% | +284.5% |
| IONS | IONIS PHARMACEUTICALS INC | $2,620,000 | +26.6% | 51,500 | 0.0% | 1.00% | +25.8% | |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $2,621,000 | -43.5% | 204,633 | -42.8% | 1.00% | -43.9% |
| ILMN | Sell | ILLUMINA INC | $2,367,000 | -75.9% | 13,641 | -76.3% | 0.90% | -76.1% |
| KITE | Sell | KITE PHARMA INC | $2,291,000 | -47.3% | 22,100 | -60.2% | 0.87% | -47.7% |
| KALV | KALVISTA PHARMACEUTICALS INC | $2,276,000 | -9.6% | 322,436 | 0.0% | 0.86% | -10.3% | |
| PRTA | PROTHENA CORP PLC | $2,274,000 | -2.9% | 42,000 | 0.0% | 0.86% | -3.6% | |
| SRPT | New | SAREPTA THERAPEUTICS INC | $2,056,000 | – | 61,000 | +100.0% | 0.78% | – |
| HZNP | Buy | HORIZON PHARMA PLC | $2,004,000 | +59.7% | 169,000 | +98.8% | 0.76% | +58.8% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $1,904,000 | +63.0% | 37,000 | +85.0% | 0.72% | +62.0% |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $1,666,000 | +70.2% | 358,975 | +81.4% | 0.63% | +68.8% |
| VCYT | VERACYTE INC | $1,414,000 | -9.3% | 170,000 | 0.0% | 0.54% | -10.1% | |
| PRTK | New | PARATEK PHARMACEUTICALS INC | $1,395,000 | – | 58,000 | +100.0% | 0.53% | – |
| SAGE | SAGE THERAPEUTICS INC | $1,353,000 | +12.0% | 16,996 | 0.0% | 0.51% | +11.3% | |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $1,351,000 | +7.1% | 11,155 | 0.0% | 0.51% | +6.2% | |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $1,235,000 | – | 41,000 | +100.0% | 0.47% | – |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $1,113,000 | +10.6% | 59,000 | 0.0% | 0.42% | +9.9% | |
| LGND | LIGAND PHARMACEUTICALS INC | $1,093,000 | +14.8% | 9,000 | 0.0% | 0.42% | +14.0% | |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $1,022,000 | -46.1% | 62,905 | -53.7% | 0.39% | -46.5% |
| MRUS | New | MERUS NV | $966,000 | – | 60,946 | +100.0% | 0.37% | – |
| MGNX | MACROGENICS INC | $945,000 | -5.9% | 54,000 | 0.0% | 0.36% | -6.5% | |
| GWPH | GW PHARMACEUTICALS PLCads | $922,000 | -17.2% | 9,200 | 0.0% | 0.35% | -17.8% | |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $902,000 | -85.6% | 20,953 | -89.5% | 0.34% | -85.7% |
| PCRX | PACIRA PHARMACEUTICALS INC | $762,000 | +4.5% | 16,000 | 0.0% | 0.29% | +3.9% | |
| PIRS | New | PIERIS PHARMACEUTICALS INC | $712,000 | – | 141,061 | +100.0% | 0.27% | – |
| Sell | TRILLIUM THERAPEUTICS INC | $693,000 | -49.2% | 161,069 | -27.4% | 0.26% | -49.6% | |
| TRXC | TRANSENTERIX INC | $625,000 | -41.9% | 889,082 | 0.0% | 0.24% | -42.5% | |
| OMER | New | OMEROS CORP | $602,000 | – | 30,239 | +100.0% | 0.23% | – |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS INC | $561,000 | -73.7% | 20,500 | -64.7% | 0.21% | -73.9% |
| XNCR | XENCOR INC | $380,000 | -11.6% | 18,000 | 0.0% | 0.14% | -12.7% | |
| ALDR | Exit | ALDER BIOPHARMACEUTICALS INC | $0 | – | -24,000 | -100.0% | -0.19% | – |
| Exit | MERUS NV | $0 | – | -33,104 | -100.0% | -0.31% | – | |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -62,000 | -100.0% | -0.50% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -60,000 | -100.0% | -0.54% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -40,264 | -100.0% | -0.67% | – |
| BGNE | Exit | BEIGENE LTDsponsored adr | $0 | – | -66,041 | -100.0% | -0.93% | – |
| ANAB | Exit | ANAPTYS BIO INC | $0 | – | -100,500 | -100.0% | -1.07% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB CO | $0 | – | -98,000 | -100.0% | -2.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-03-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.